Harvard Bioscience Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Harvard Bioscience Stock Forecast and Price Target
Given the average yearlong price target of $7.00 provided by two prominent analysts over the past few months, there is a potential upside of approximately 89.7% from the last closing price in April, 2024 for Harvard Bioscience's stock if it is reached. This estimation is based on a high estimate of $7.00 and a low estimate of $7.00. If you're interested in investing in this company, why not also look at its competitors to see how they are doing?
89.70% Upside
Harvard Bioscience Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Harvard Bioscience's Price has gone down from $3.67 to $0.00 – a 100.00% drop. In the next year, analysts believe that Fair Value will reach $5.97 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| TMO Stock Forecast | Thermo Fisher Scientific | Outperform |
10
|
$577.39 | Buy/Sell | $591.94 | 6.51% |
| DHR Stock Forecast | Danaher | Outperform |
10
|
$250.41 | Buy/Sell | $260.33 | 7.82% |
| BDX Stock Forecast | Becton Dickinson and Co | Outperform |
9
|
$233.83 | Buy/Sell | $284.47 | 19.75% |
| LONN Stock Forecast | Lonza Group | Buy |
16
|
CHF522.80 | Buy/Sell | CHF516.89 | 11.90% |
| BIO Stock Forecast | Bio-Rad Laboratories Inc | Buy |
16
|
$278.21 | Buy/Sell | $536.80 | 56.97% |
Harvard Bioscience Revenue Forecast for 2023 - 2025 - 2030
Harvard Bioscience's Revenue has seen impressive growth In the last three years, rising from $102.10M to $112.25M – a growth of 9.94%. In the next year, analysts believe that Revenue will reach $120.50M – an increase of 7.35%. For the next seven years, the forecast is for Revenue to grow by 12.96%.
.jpg)
Harvard Bioscience EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Harvard Bioscience's EBITDA has seen an increase, rising from $7.85M to $9.49M. This represents a growth of 20.89%. Analysts predict that Harvard Bioscience's EBITDA will increase in the upcoming year, reaching $19.70M. This would represent an increase of 107.59%. Over the next seven years, experts predict that Harvard Bioscience's EBITDA will grow at a rate of 66.76%.
Harvard Bioscience EBIT Forecast for 2023 - 2025 - 2030
Harvard Bioscience's EBIT has seen growth In the last three years, going from $220.00k to $2.50M – a gain of 1036.36% In the next year, analysts believe that EBIT will reach $17.40M – an increase of 596.00%. For the next seven years, the forecast is forEBIT to grow by 764.01%.
Harvard Bioscience EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Harvard Bioscience's EPS has gone down from $0.16 to $0.00 – a 100.00% drop. In the next year, analysts believe that EPS will reach $0.26 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)